These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38978730)

  • 41. Clinical efficacy and safety of paclitaxel plus carboplatin as neoadjuvant chemotherapy prior to radical hysterectomy and pelvic lymphadenectomy for Stage IB2-IIB cervical cancer.
    Yang L; Guo J; Shen Y; Cai J; Xiong Z; Dong W; Min J; Wang Z
    Int J Clin Exp Med; 2015; 8(8):13690-8. PubMed ID: 26550314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term survival following neoadjuvant chemotherapy and concomitant radiochemotherapy in locally advanced cervical cancer: results of the Oncology Institute "Prof. Dr. Ion Chiricuta" experience.
    Marita A; Ordeanu C; Rancea A; Nicolae T; Nagy VM
    J Med Life; 2018; 11(1):42-50. PubMed ID: 29696064
    [No Abstract]   [Full Text] [Related]  

  • 43. Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio.
    Yu J; Huang L; Dong T; Cao L
    J Obstet Gynaecol; 2024 Dec; 44(1):2361858. PubMed ID: 38864403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
    Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-dense Paclitaxel- and Carboplatin-based Neoadjuvant Chemotherapy Followed by Surgery or Concurrent Chemo-radiotherapy in Cervical Cancer: a Preliminary Analysis.
    Gadducci A; Barsotti C; Laliscia C; Cosio S; Fanucchi A; Tana R; Fabrini MG
    Anticancer Res; 2017 Mar; 37(3):1249-1255. PubMed ID: 28314289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
    Ma K; Yang YH; Yang X; Feng ZY; Liu TY; Wen HW; Liao QP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):910-5. PubMed ID: 24343073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy of neoadjuvant chemotherapy in different histological types of cervical cancer.
    He L; Wu L; Su G; Wei W; Liang L; Han L; Kebria M; Liu P; Chen C; Yu Y; Zhong M; Wang W
    Gynecol Oncol; 2014 Aug; 134(2):419-25. PubMed ID: 24918866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: A systematic review and updated meta-analysis.
    Lu W; Lu C; Yu Z; Gao L
    Oncol Lett; 2021 Feb; 21(2):160. PubMed ID: 33552278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research.
    Gadducci A; Cosio S
    Anticancer Res; 2020 Sep; 40(9):4819-4828. PubMed ID: 32878770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma.
    Wang Q; Xu G; Xia Y; Zuo J; Zeng G; Xue Z; Cao R; Xiong W; Li W
    Oral Oncol; 2020 Dec; 111():104925. PubMed ID: 32721816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The efficacy and safety of concurrent chemoradiotherapy with induction chemotherapy
    Liu Y; Yang L; Zhang S; Lin B
    Transl Cancer Res; 2022 May; 11(5):1207-1218. PubMed ID: 35706809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial.
    Gupta S; Maheshwari A; Parab P; Mahantshetty U; Hawaldar R; Sastri Chopra S; Kerkar R; Engineer R; Tongaonkar H; Ghosh J; Gulia S; Kumar N; Shylasree TS; Gawade R; Kembhavi Y; Gaikar M; Menon S; Thakur M; Shrivastava S; Badwe R
    J Clin Oncol; 2018 Jun; 36(16):1548-1555. PubMed ID: 29432076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis.
    Lan M; Chen C; Huang Y; Tian L; Duan Z; Han F; Liao J; Deng M; Sio TT; Prayongrat A; Zheng L; Wu S; Lu T
    Sci Rep; 2017 Feb; 7():42624. PubMed ID: 28211482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of therapeutic efficacy and toxicity of docetaxel, cisplatin, and fluorouracil (TPF)-based induction chemotherapy plus concurrent chemoradiotherapy and chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma.
    Chen R; Lu Y; Zhang Y; He R; Tang F; Yuan W; Li Y; Zhang X
    Medicine (Baltimore); 2021 Oct; 100(42):e27475. PubMed ID: 34678878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neoadjuvant chemotherapy efficacy and prognostic factors in 187 cervical cancer patients with IB2 and IIA2 stage.
    Zou T; Zheng C; Zhang Z; Yu L; Fu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):297-304. PubMed ID: 32386022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical efficacy analysis of preoperative neoadjuvant chemotherapy with high-dose dense paclitaxel plus cisplatin in Stages IB2, IIA2, IIB cervical cancer in Iran.
    Mousavi AS; Hashemi FS; Gilani MM; Akhavan S; Shariat M
    Eur J Gynaecol Oncol; 2016; 37(5):703-709. PubMed ID: 29787015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis.
    Wang BC; Xiao BY; Lin GH; Wang C; Liu Q
    BMC Cancer; 2020 May; 20(1):393. PubMed ID: 32375701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.
    Wang J; Xiao L; Wang S; Pang Q; Wang J
    Front Oncol; 2021; 11():665231. PubMed ID: 34589418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
    Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
    Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study.
    Benedetti-Panici P; Greggi S; Colombo A; Amoroso M; Smaniotto D; Giannarelli D; Amunni G; Raspagliesi F; Zola P; Mangioni C; Landoni F
    J Clin Oncol; 2002 Jan; 20(1):179-88. PubMed ID: 11773168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.